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The design of multifunctional nanofluids is highly desirable for biomedical therapy/cellular
imaging applications.[1–4] The emergence of hybrid nanomaterials with specific properties,
such as magnetism and fluorescence, can lead to an understanding of biological processes at
the biomolecular level.[1] Various hybrid systems have been analyzed in the recent past for
several possible biomedical applications.[5–9] Carbon-based hybrid systems such as carbon
nanotubes with various nanoparticles are being widely tested for their biological applications
because of their ability to cross cell membranes and their interesting thermal and electrical
properties.[10,11] Graphene oxide (GO) is a fairly new graphene-based system with a 2D
carbon honeycomb lattice decorated with numerous functional groups attached to the
backbone: these functional groups make it an excellent platform for further attachment of
nanoparticles and synthesis of hybrid materials. Cell viability studies on GO have been
recently attempted, showing biocompatibility. [12,13] Moreover, the intrinsic
photoluminescence (PL) properties of GO can be utilized for cellular imaging.[13] The large
surface area and non-covalent interactions with aromatic molecules make GO an excellent
system for biomolecular applications and drug attachment.
On the other hand, magnetic-field-assisted biomolecular imaging, drug delivery, and therapy
have received tremendous attention in nano-biotechnology since the proposal of magnetic
materials for hyperthermia treatment of cancer, in 1957.[14] Iron oxide (Fe3O4) occupies a
unique position among the various magnetic materials as a result of its considerable
saturation magnetization (87 emu g−1), interesting transport properties, and, above all, high
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bio-compatibility.[2] Aqueous ferrofluids based on superparamagnetic iron oxide (SPION,
ultrafine Fe3O4 nanoparticles having size ~10 nm) are well proven for their biomedical
applications such as magnetic hyperthermia (using their radio-frequency power loss),
magnetic contrast enhancement, enzyme immobilization, and drug targeting and delivery.
[10]
The advent of state-of-the-art biomedical imaging tools has helped the development of cell
imaging/tracking or gene monitoring with high temporal and spatial resolution.[15,16] Non-
invasive multimodality techniques are also rapidly changing the evolving field of
experimental imaging based on genetic expression and thus becoming suitable for future
clinical practice. Each imaging technique has its own limitations, and multimodality imaging
agents can address this hurdle. Magnetic resonance imaging (MRI) is an important
diagnostic tool and is unique in its ability to generate 3D images of opaque and soft tissues
with high spatial resolution. More interestingly, contrast in MR images arising from the
variation in inherent relaxation times can be manipulated using contrast agents. But, despite
its competitive molecular imaging capability, the inherent low sensitivity of the MRI
technique demands the synthesis of high contrast enhancement agents. This has led to the
use of nanoparticles of gadolinium (Gd, paramagnetic) and iron oxide (ferromagnetic/
superparamagnetic) as high relaxivity contrast enhancement agents.
Hybrid materials can also enable non-invasive imaging methods and diagnosis protocols by
combining the unique properties of the individual system. Advances in nanotechnology have
led to the development of hybrid versions of these nanoparticles, which can improve upon
the low sensitivity of MRI by other techniques such as fluorescence. Fluorescence allows
bio-imaging with high speed and sensitivity. It has been established that a combination of
magnetic and fluorescent imaging techniques with nanostructured systems will be beneficial
for in vivo disease diagnosis and in vitro monitoring of living cells.[17] However, the
synthesis of highly luminescent biomaterials using ferromagnetic/superparamagnetic Fe3O4
is a complicated development owing to the fluorescence quenching property of Fe3O4.
Researchers have developed lumino-magnetic phosphors for cell imaging applications, [18]
but all those nanophosphor materials are paramagnetic in nature, limiting their bio-
applications with low magnetic field assistance. Such a multimodality technique can
combine the high spatial (50 μm) and temporal resolution of MRI with the high sensitivity
of optical imaging probes, and most MRI/optical multimodal agents are based on organic
dyes.[1] Though SPIONs have been commercially identified for their applications in T2-
weighted MRI contrast enhancement, other imaging modalities using bare SPIONs cannot
be realized. Recently, core/shell nanoparticles with SPIONs and polymer-passivated SPION/
metallic hybrid structures have proven their efficacy in other modalities such as optical
imaging, magnetomotive photoacoustic imaging, and scattering-based imaging.[19–21]
Here we report the synthesis and demonstration of a single hybrid nanosystem for dual-
mode cellular imaging using PL and MRI. An aqueous suspension of 2D nanofillers of GO-
Fe3O4 (GO-F) at neutral pH (~7) is synthesized by a simple chemical route. Recently, there
have been some reports on the synthesis of iron oxide functionalized GO particles by
different chemical routes,[22–24] but the material has not been exploited in bio-imaging
applications. Here we discuss a detailed PL study conducted on this nanofluid and its in
vitro cancer cell imaging, hence demonstrating GO-F as a possible multimodalagent without
any cell cytotoxicity. Direct use of iron oxide (Fe3O4/γFe2O3) for targeted drug delivery is
not efficient owing to a “drug burst” effect (quick release of the drug upon injection) before
the desired site is reached, and GO-F may be a better candidate since it has been
demonstrated using Rhodamine molecules that aromatic drug molecules can be directly
attached to the GO lattice. [25–27] In addition, theoretical evaluation of radio frequency
power loss by measuring the specific absorption rate (SAR) for Fe3O4 nanoparticles having
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size ~10 nm shows high values, indicating their suitability for applications in magnetic
hyperthermia.[28] However, the heat transfer ability of Fe3O4-based ferrofluid is
comparatively poor. The high heat transfer ability/thermal conductivity of GO can make
GO-F an ideal material for hyperthermia applications.
Development of a GO-SPION-based hybrid system will also help in the investigation of the
role of different parameters, such as surface roughness, functional groups, and shape/
morphology of nanoparticles, in creating bio/nano interfaces.[29–31] Mahmoudi and
Serpooshan proved that SPIONs with jagged surfaces can absorb various biomolecules/
proteins much more strongly than SPIONs with smooth surfaces.[29] The GO flake platform
also has considerable surface roughness and contains many functional groups, making it a
unique material for understanding the biophysical properties at bio/nano interfaces.
We studied nanofluid stability using zeta potential measurements (Malvern Zen 3600
Zetasizer) along with measurements of the hydrodynamic radius of the particles by dynamic
light scattering. The zeta potential of GO-F is −48.7 mV, indicating “good stability” of the
nanofluid. This guarantees a long shelf-life. The hydrodynamic radius of GO-F was found to
be ~583 nm. In situ chemical synthesis allows Fe3O4 nanoparticles to be covalently attached
on to the GO surface.[16] Hence, the GO-F stable suspension is formed through the oxygen
functionalities of GO with Fe3O4. Small flakes of GO, after sonication for 3 h, were fully
suspended in water for 2 days. A schematic of GO-F is shown in Figure 1a. Epoxy,
carboxyl, or hydroxyl groups available in GO make it chemically bond with Fe3O4. This
was further verified by Fourier transform infrared (FTIR) analysis.
A TEM image of GO-F is shown in Figure 1b. The Fe3O4 nanoparticles having a size of
approximately 10 nm are uniformly distributed in GO. High-resolution TEM (HRTEM)
images and a selected area electron diffraction (SAED) image showing the (311) lattice
plane of Fe3O4 (with dark contrast) are shown in the Supporting Information (Figure S1). In
order to prove the graphitic nature of the nanocomposite sample, micro-Raman studies were
conducted with GO-F powder; the result is shown in Figure 1c. Graphitic G (order) and D
(disorder) Raman modes are marked in the figure. The higher intensity G peak indicates the
extent of graphitization of the sample. The inset in this figure is a photograph of a stable
GO-F suspension. The magnetic nature of the powder was verified using a vibrating sample
magnetometer (VSM). The room temperature (300 K) magnetization M(H) curve is depicted
in Figure 1d. The sample shows a typical superparamagnetic S-like curve, which indicates
the contribution of ultrafine Fe3O4. The XRD pattern of the GO-F powder is shown in
Figure 1e. It consists of broad amorphous-like peaks around 24° and 44°, corresponding to
GO having a lattice spacing of ~0.39 nm. The XRD results also indicate the presence of
Fe3O4 (International Centre for Diffraction Data, ICDD: 750449). FTIR spectra of GO and
GO-F are shown in Figure 1f. The presence of different types of oxygen functionalities in
GO is evident from peaks corresponding to oxygen stretching vibration (2900–3600 cm−1, –
OH vibration), C=O stretching vibration (1720 cm−1), C–OH stretching vibration (1220
cm−1), and C–O stretching vibration (1060 cm−1) in Figure 1f (dark line). Moreover, the
signature of aromatic C=C stretching at ~1600 cm−1 indicates the presence of the sp2
hybridized honeycomb lattice. The GO-F also contains these functional groups, but the
positions of the bonds are red shifted and the sharpness of the peaks is changed, particularly
that of aromatic C=C bonding (Figure 1e; light line). This indicates the change in the
coordination environment of various functional groups in GO-F. Peaks between 400 and 700
cm−1 correspond to those of Fe-O in Fe3O4. The shift in the peak position and modification
of C=C bonding is proposed as evidence for covalent bonding in GO with other
nanoparticles. The presence of iron oxide in GO-F is further understood from the XPS
analysis. The Fe 2p XPS spectrum of GO-F is shown in Figure 1f (the complete XPS
spectrum is provided in Figure S2 in the Supporting Information). The peaks of Fe 2p1/2
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and Fe 2p3/2 at 710.9 eV and 725 eV, respectively, establish the fact that the iron oxide in
the sample is Fe3O4. To explore the facets of chemical interactions, interfacial effect, and
associated optical properties of GO-F nanofluid, we characterized the pristine GO, Fe3O4
ferrofluid, and GO-F suspensions (in water) through UV-visible absorption spectroscopy.
Figure 2a shows the absorption spectra of Fe3O4, GO, and GO-F. The absorption result
reveals that GO-F is optically transparent in the 700–800 nm range. A blue shift of the
absorption edge is noticed when the absorption spectrum of GO-F is compared to that of
Fe3O4 ferrofluid. A higher concentration of Fe3O4 nanoparticles in GO strengthens such
effects and therefore leads to the blue shift of the absorption spectrum. The blue shift of the
absorption edge for GO-F can be attributed to two factors: a) the integration effect in the
bandgap due to composite formation between GO (1.70 eV)[32] and Fe3O4 (~2.9 eV), [33]
and b) the surface interaction and interface formation effect between Fe3O4 and functional
groups present in GO.[34,35] The absorption peak at ~250 nm throws light onto the fact that a
strong interface has formed between GO and Fe3O4 (since the absorption peaks of pristine
GO and Fe3O4 are observed at ~228 nm and ~354 nm, respectively). This has been further
confirmed by PL spectroscopy.
Figure 2b exhibits the PL emission spectrum of Fe3O4 ferrofluid. An emission peak is
observed at 416 nm upon excitation at 365 nm wavelength(3.39 eV) and Figure 2c
represents the corresponding PLE (excitation) spectrum for Fe3O4 nanoparticles at 416 nm
(2.98 eV) emission of Fe3O4 nanoparticles. The observed result is consistent with other
reports.[36] To investigate further the chemical interaction and the interface formation
between GO and Fe3O4, rigorous PL studies on the GO-F hybrid system were performed.
PL results are shown in Figures 2d–f. In order to confirm the interface formation, we excited
the hybrid system at 365 nm wavelength, which will help to make a comparative study with
Fe3O4. Interestingly, the PL emission spectrum of the GO-F hybrid system shows two
strong peaks. One of them can be attributed to Fe3O4 and the other to the interface formation
between GO and Fe3O4, as expected, through oxygen functionalities. In order to ensure that
the extra peak represents the interface formation, we performed a PLE experiment. This will
compute the actual excitation of the GO-F hybrid system. Figure 2e is the PLE spectrum of
GO-F at 469 nm emission. Figure 2f shows strong blue peak emission centered at 469 nm
with estimated color coordinates x = 0.2035, y = 0.2427 of the GO-F nanocomposite at 324
nm excitation wavelength. Moreover, we also performed PL emission spectroscopy of the
pristine GO sample at 324 nm excitation to ensure that the additional peak is due to interface
formation (Figure 2h). The enhanced luminescence in GO-F arises from the interface
between GO and Fe3O4 nanoparticles through oxygen functionalities, that is, carboxyl,
carbonyl, epoxy, and hydroxyl groups, present in GO nanoparticles. A strong blue emission
of the hybrid is ascribed to the integration of surface effects of GO-F and optical emission of
Fe3O4 nanoparticles.
To know the efficacy of the GO-F nanofluid system as an efficient fluorescent marker, we
performed time-resolved photoluminescence (TRPL)spectroscopy. Luminescence decay
profiles of GO-F are shown in Figure 2i. Decay was recorded for the GO-F transitions at 469
nm for emission at 371 nm excitation measured at room temperature by a time-correlated
single photon counting technique. Lifetime data of the GO-F hybrid were very well fitted to
a double-exponential function as shown in Figure 2i. Parameters generated from iterative
reconvolution of the decay with the instrument response function (IRF) are listed in Figure
2j. Observed lifetimes of the GO-F are τ1 = 0.70 ns and τ2 = 4.80 ns. For double-
exponential decay, the average lifetime, τav, is determined by[15,37,38]
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(1)
The average lifetime of this GO-F system is estimated to be τav ~ 4.65 ns. The observed
lifetime of GO-F is in nanoseconds, suggesting that the synthesized GO-F hybrid material is
most suitable for biological applications.
As hypothesized, GO-F hybrid nanosuspensions can be used for biological applications such
as bioimaging, cell tracking, and drug delivery, if the inherent toxicity of the material allows
it. Therefore, the cytotoxicity of GO-F was evaluated using the MTT viability assay with
two different human breast cancer cell lines, MDA-MB-231 and T47D, for the indicated
period of time. As shown in Figure 3 (Figure S4), no marked cell death or proliferation
defects were observed with cells cultured in GO-F suspensions compared to the untreated
control cells, suggesting that GO-F does not pose any considerable toxicity problem to the
cells.
To determine whether the GO-F hybrid can be used for cellular imaging, we performed in
vitro cellular imaging studies using the human breast cancer cell line T47D. Figure 4a shows
fluorescent microscopy images of T47D cells treated with GO-F for 24 h (its
biocompatibility is shown in Figure S4; cell viability is consistent with the study on the
other cell line MDA-MB-231). The blue fluorescent GO-F is distributed inside the
cytoplasm as shown in Figures 4aii, iii, v, and vi. The Figures 4aiv–vi show magnified views
of individual T47D cells treated with GO-F. The overlap of fluorescence and phase contrast
images clearly shows the cellular localization of GO-F (an individual cell staining is shown
in Figure S4 in the Supporting Information; it indicates that the nanoparticles are distributed
outside the cell nucleus and inside the cell cytoplasm). Another breast cancer cell line named
SUM159PT, which is a metastatic breast cancer cell, was also imaged using the fluorescence
of GO-F and is shown in Figure S5 in the Supporting Information.
Nowadays, MRI is widely used to aid the diagnosis of many medical disorders. It is a safe
non-invasive technique for medical imaging compared to other techniques such as X-ray
computer tomography, where ionizing radiations are used. Moreover, owing to subtle
physicochemical differences between organs and tissues, MRI is capable of differentiating
tissue type and diseases that may not be detected by other imaging techniques. In order to
evaluate GO-F as a potential MRI T2 contrast agent, GO-F was suspended in agarose in
graded concentrations and T2 values were measured on a 7T MR scanner with a multi-slice
multi-echo (MSME) sequence. The results were fitted into a three-parameter spin–spin
relaxation equation using Matlab. The T2 value of 2% agarose phantom was greatly reduced
from 111.9 to 33.8 and 61.7 ms when doped with 100 μg mL−1 and 10 μg mL−1 GO-F,
respectively. T2-weighted MR images are shown in Figure 4b. To calculate molar relaxivity,
we used XPS to determine the elemental percentage of iron in GO-F. On a molar basis, GO-
F was 63.42% carbon, 35.64% oxygen, and 0.94% iron. Based on GO-F’s iron content, its
T2 relaxivity was 297.06 mM−1 s−1. As expected, GO-F did not enhance T1 relaxivity. High
contrast even with 100 μg mL−1 (with these amounts no cell death has been observed)
indicates that GO-F is a unique material for MRI clinical imaging. In order to find
applications of this magnetic GO-F in other fields, such as therapy, thermal conductivity
measurements have been conducted and details are provided in the Supporting Information.
Enhanced thermal conductivity of GO-F also shows its possibilities in magnetic
hyperthermia.
In conclusion, we have demonstrated a 2D hybrid nanostructure-based nanofluid that can be
used as a contrast agent in a dual mode imaging process, and that allows one to easily
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combine two complementary techniques (T2 MRI and optical fluorescence imaging) in
cellular imaging. An interfacial energy transfer mechanism has been identified for the PL of
GO-F. The time-resolved spectroscopy measurements reveal a nanosecond decay for hybrid
GO-F fluid, indicating its potential applications in biological systems. The hybrid GO-F
fluid showed good cell viability with different cancer cell lines. This nanofluid exhibited an
enhanced thermal conductivity and the nanoparticles of GO-F were found to penetrate the
cell cytoplasm, making it viable for intra-cellular magnetic hyperthermia applications. The
surface functionalities in GO provide a good platform for large loading of aromatic drug
molecules, thereby avoiding “drug burst” effects associated with bare SPIONs.
Experimental Section
GO-F synthesis
GO was synthesized in water using a modified Hummers’ method as previously reported.
[39] Uniformly sized Fe3O4 nanoparticles were synthesized within the GO suspension using
a chemical co-precipitation technique. FeSO4·7H2O (1 mL, 0.1 M) and FeCl3 (1 mL, 0.2 M)
were placed in a conical flask and mixed well using sonication. 1 mL of this solution was
added to 10 mL of the GO suspension and magnetically stirred for half an hour. Ammonia
solution was dropped into this mixture with constant stirring until the pH of the solution
reached 10 and the Fe3O4 nanoparticles started to precipitate within the GO. As soon as the
pH reached 10, a 3 M citric acid solution was added dropwise while the solution was heated
to 75 °C with constant magnetic stirring for 30 min. This solution was filtered (100 nm
Teflon filter paper) and washed several times using distilled water until neutral pH was
reached. The resultant filtrate was re-dispersed in distilled water using extensive sonication.
Characterization tools
The structural and morphological analyses of GO-F powder were carried out using HRTEM
(JEM 2100F transmission electron microscope), and the Raman study was conducted using a
micro-Raman spectroscope (Renishaw, inVia). Room temperature magnetic properties were
probed using a VSM. XRD studies were conducted using Cu Kα radiation. FTIR studies on
the sample were performed using a Nicolet FTIR microscope, while XPS was carried out
using a PHI Quantera X-ray photoelectron microscope. UV-vis spectra were collected using
a high resolution UV-vis spectrophotometer (Shimadzu, model no. UV-2450) using quartz
cells with a 10 mm path length. PL characterization was conducted using a luminescence
spectrometer (NanoLog, Horiba Jobin Yvon) with a xenon lamp as the source of excitation.
TRPL was recorded using a time-correlated single photon counting technique with an
Edinburgh Instruments spectrometer (model No. FLSP-920) and picosecond laser diode as
the source of excitation.
Cytotoxicity and cellular imaging methods
The cells were cultured and maintained in Dulbecco’s Modified Eagle’s Medium (DMEM),
high glucose 1X (Invitrogen), containing 4.5 g L−1 D-glucose, 4 mM L-glutamine, and 110
mg L−1 sodium pyruvate, with 10% fetal bovine serum (FBS), 100 IU mL−1 penicillin, and
100 μg mL−1 streptomycin. For the cytotoxicity assay, MDA-MB231 and T47D cells (5 ×
103 cells per well) were cultured in 96-well plates, overnight. Different concentrations of
GO-F (0–100 μg mL−1) in culture media were added to each well in triplicate. After24 h and
48 h of culture with GO-F, cells were washed gently with 200 μL warm, sterile phosphate-
buffered saline (PBS), and then 200 μL/well of MTT reagent [3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenytetrazolium bromide (4 mg mL−1)] was added. After 4 h of
incubation, MTT reagent was removed and 200 μL of dimethyl sulfoxide (DMSO) was
added per well and incubated for an additional 5 min at room temperature. The optical
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density of solubilized formazan salts was assessed at 570 nm in a Tecan Infinite M200
microplate reader (Männedorf, Switzerland).
For imaging, 1 × 104 cells/well were plated in four-well sterile chamber slides (Nunc,
Rochester, NY) with 500 μL culture medium. After overnight culture, 50 μg mL−1 GO-F
suspension was added to the culture medium and incubated under regular cell culture
conditions. After 4 h and 24 h of culture, medium with GO-F was removed from the cells
and washed two times with 1 mL 1X PBS. Cells were fixed using 1% paraformaldehyde and
mounted with Vectashield antifade mounting media (Vector Laboratories, Burlingame, CA).
Cellular imaging was carried out using a Nikon Eclipse 90i microscope equipped with the
Cool SnaP HQ2 CCD camera (Photometrics, Tucson, AZ). A Nikon Intensilight C-HGFI
lamp was used as the fluorescence light source.
Thermal conductivity measurements on GO-F
The effective thermal conductivities of nanofluids were measured using a thermal properties
analyzer (Decagon Devices Inc., Pullman, WA, model KD2 Pro). This device is based on
the transient hot-wire technique. Here, a finite-length wire is completely immersed in a finite
volume of GO-F. While the wire is heating up, the change in resistance (thus its
temperature) is measured as a function of time using a Wheatstone bridge circuit. The
thermal conductivity (TC) value is determined from the heating power and the slope of the
temperature change with logarithmic time scale. The instrument uses a 1.3 mm diameter by
60 mm long stainless steel probe that is immersed in the nanofluids to obtain the thermal
conductivity. The instrument was calibrated using glycerin and measurement was verified
up to three decimal places.
T2 MRI measurements
In order to evaluate GO-F as a potential MRI T2 contrast agent, agarose phantoms were
made with GO-F. Their T2 values were measured on a 7T MR scanner with a MSME
sequence and the results were fitted to a three-parameter spin–spin relaxation equation using
Matlab.
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Figure 1.
a) Schematic of the hybrid GO-F. Fe3O4 nanoparticles are covalently attached to the
graphene plane through oxygen functionalities. b) Transmission electron microscopy (TEM)
image of GO-F showing the Fe3O4 nanoparticles distributed throughout GO. c) Micro-
Raman spectrum. Graphitic order and disorder (G and D) Raman modes are marked.
Photograph: GO-F suspension in water. d) Room temperature magnetization curve of GO-F
powder. The S-like M(H ) loop shows the superparamagnetic nature of the GO-F powder
(paramagnetic contribution from the graphite lattice is not subtracted). e) X-ray diffraction
(XRD) of GO-F. f) FTIR of GO (dark line) and GO-F (dots) g) Fe 2p X-ray photoelectron
spectroscopy (XPS) spectrum of GO-F.
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Figure 2.
a) UV-vis absorption spectra of Fe3O4, GO, and GO-F fluids. b) Room temperature PL
emission spectrum of Fe3O4 nanoparticles at 365 nm excitation. c) PL excitation spectrum at
416 nm emission of Fe3O4 nanoparticles. d) PL emission spectrum of GO-F nanofluid at
365 nm excitation. e) PL excitation spectrum at 416 nm emission of GO-F nanofluid. Note
that an additional interface peak appears after GO forms an interface with Fe3O4. f) PL
emission spectrum of GO-F nanofluid at 324 nm excitation. g) The color coordinate of the
blue emission. h) PL emission spectrum of GO at 324 nm excitation. i) TRPL decay profile
of GO-F nanofluid recorded at room temperature while monitoring the emission at 469 nm
at an excitation wavelength of 371 nm. j) The lifetime data and the parameter generated by
the exponential fitting.
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Figure 3.
Cell viability assay with human breast cancer cell lines MDA-MB-231. Cells were treated
with different concentrations of GO-F. No significant cytotoxicity was observed with
various doses of GO-F treatment.
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Figure 4.
a) In vitro fluorescence microscopy images of T47D cells treated with GO-F (50 μg mL−1)
for 24 h. i–iii) Low magnification images of T47D cells: i) Phase contrast picture, ii)
fluorescence images of GO-F, and iii) overlay of images (i) and (ii). iv–vi) High
magnification images of an individual T47D cell: iv) phase contrast picture of an individual
T47D cell, v) fluorescence image of GO-F, and vi) overlay of images (iv) and (v). The
overlay of the phase contrast and fluorescence images clearly demonstrates the localization
of GO-F in the cellular cytoplasm, suggesting its suitability for bioimaging. b) T2-weighted
MR image showing strong T2 contrast in agarose phantoms. It shows alginate phantoms
doped with different concentrations (as shown) of GO-F. The T2-weighted image was
acquired in a 7T scanner with multi-slice multi-echo sequence. The T2 relaxivity was 297.06
mM−1 s−1.
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